Larimar Therapeutics to Present at Jefferies Virtual Healthcare Conference
Larimar Therapeutics, Inc. (Nasdaq:LRMR) announced that Dr. Carole Ben-Maimon, President and CEO, will present at the Jefferies Virtual Healthcare Conference on June 3, 2020, at 4:30 p.m. EDT. The presentation will focus on the company’s advancements in developing treatments for complex rare diseases such as Friedreich’s ataxia. Interested investors can access a live audio webcast from the Investors section of Larimar’s website, which will also feature an archived version available for 30 days post-event.
- None.
- None.
BALA CYNWYD, Pa., May 29, 2020 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Nasdaq:LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that Carole Ben-Maimon, MD, President and Chief Executive Officer, will present at the Jefferies Virtual Healthcare Conference on Wednesday, June 3, 2020, at 4:30 p.m. EDT.
A live audio webcast of the presentation will be accessible from the Events & Presentations page of the Investors section of Larimar’s website, https://investors.larimartx.com. An archived version of the webcast will be available on the website for 30 days following the event.
About Larimar Therapeutics
Larimar Therapeutics, Inc. (Nasdaq:LRMR), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. The company’s lead compound, CTI-1601, is currently being evaluated in a Phase 1 clinical program as a potential treatment for Friedreich’s ataxia, a rare and progressive genetic disease. Larimar also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds. For more information, please visit: https://larimartx.com.
Investor Contact:
John Woolford
Westwicke
john.woolford@westwicke.com
443-213-0506
Media Contact:
Gina Cestari
6 Degrees
(917) 797-7904
gcestari@6degreespr.com
FAQ
When is Larimar Therapeutics' presentation at the Jefferies Virtual Healthcare Conference?
Where can I watch the Larimar Therapeutics presentation?
What is the focus of Larimar Therapeutics?
What is the ticker symbol for Larimar Therapeutics?
How long will the archived version of the webcast be available?
